Search: onr:"swepub:oai:DiVA.org:uu-10503" > Human Tousled like ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03008naa a2200505 4500 | |
001 | oai:DiVA.org:uu-10503 | |
003 | SwePub | |
008 | 070327s2003 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-105032 URI |
024 | 7 | a https://doi.org/10.1093/emboj/cdg1512 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Groth, Anja4 aut |
245 | 1 0 | a Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint |
264 | 1 | b Wiley,c 2003 |
338 | a print2 rdacarrier | |
520 | a All eukaryotes respond to DNA damage by modulation of diverse cellular processes to preserve genomic integrity and ensure survival. Here we identify mammalian Tousled like kinases (Tlks) as a novel target of the DNA damage checkpoint. During S-phase progression, when Tlks are maximally active, generation of DNA double-strand breaks (DSBs) leads to rapid and transient inhibition of Tlk activity. Experiments with chemical inhibitors, genetic models and gene targeting through RNA interference demonstrate that this response to DSBs requires ATM and Chk1 function. Chk1 phosphorylates Tlk1 on serine 695 (S695) in vitro, and this UCN-01- and caffeine-sensitive site is phosphorylated in vivo in response to DNA damage. Substitution of S695 to alanine impaired efficient downregulation of Tlk1 after DNA damage. These findings identify an unprecedented functional co- operation between ATM and Chk1 in propagation of a checkpoint response during S phase and suggest that, through transient inhibition of Tlk kinases, the ATM-Chk1-Tlk pathway may regulate processes involved in chromatin assembly. | |
653 | a Base Sequence | |
653 | a Cell Cycle Proteins | |
653 | a Cell Line | |
653 | a DNA Damage | |
653 | a DNA Primers | |
653 | a DNA-Binding Proteins | |
653 | a Humans | |
653 | a Mutagenesis; Site-Directed | |
653 | a Phosphorylation | |
653 | a Protein Kinases/*metabolism | |
653 | a Protein-Serine-Threonine Kinases/antagonists & inhibitors/*metabolism | |
653 | a S Phase | |
653 | a Tumor Suppressor Proteins | |
700 | 1 | a Lukas, Jiri4 aut |
700 | 1 | a Nigg, Erich A.4 aut |
700 | 1 | a Silljé, Herman H. W.4 aut |
700 | 1 | a Wernstedt, Christeru Uppsala universitet,Ludwiginstitutet för cancerforskning4 aut0 (Swepub:uu)chrisws |
700 | 1 | a Bartek, Jiri4 aut |
700 | 1 | a Hansen, Klaus4 aut |
710 | 2 | a Uppsala universitetb Ludwiginstitutet för cancerforskning4 org |
773 | 0 | t EMBO Journald : Wileyg 22:7, s. 1676-1687q 22:7<1676-1687x 0261-4189x 1460-2075 |
856 | 4 | u http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=12660173&dopt=Citation |
856 | 4 | u https://europepmc.org/articles/pmc152895?pdf=render |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-10503 |
856 | 4 8 | u https://doi.org/10.1093/emboj/cdg151 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.